54755-69-0

Usage

Uses

Used in Pharmaceutical Research:
2-Hydroxy-4-benzyloxycarbonylamine butanoic acid is used as a building block in pharmaceutical research for the development of new drugs and medications. Its unique structure and functional groups make it a versatile component in the synthesis of various pharmaceutical compounds.
Used in Medicinal Chemistry:
2-Hydroxy-4-benzyloxycarbonylamine butanoic acid is used as a valuable compound in medicinal chemistry due to its anti-inflammatory and anti-cancer properties. Its potential therapeutic applications make it a promising candidate for further research and development in the field of medicine.
Used in Organic Synthesis:
2-Hydroxy-4-benzyloxycarbonylamine butanoic acid is used as a building block in organic synthesis, allowing for the creation of a wide range of chemical compounds with various applications. Its versatility and reactivity make it an essential component in the synthesis of complex organic molecules.

Upstream product

• 501-53-1 benzyl chloroformate 
• 13477-53-7 4-amino-2-hydroxybutyric acid 
• 54755-77-0 N-benzyloxycarbonyl-3-aminopropionic acid methyl ester 

Downstream Products

• 40371-50-4 S-4-benzyloxycarbonylamino-2-hydroxybutyric acid 
• 42491-77-0 (R)-4-benzyloxycarbonylamino-2-hydroxybutanoic acid 
• 57078-37-2 N-hydroxy-5-norbornene-2,3-dicarboximide ester of N-benzyloxycarbonyl-DL-2-hydroxy-4-aminobutanoic acid 
• 66962-71-8 4-N-(D,L-2-hydroxy-4-aminobutanoyl)glycyl-tetra-N-benzyloxycarbonylfortimicin B 

Relevant academic research and scientific papers

Amine-Functionalized Polylactide-PEG Copolymers

The formation of halogenated carboxylic acid intermediate followed by a ring-closing reaction led to amino-functionalized asymmetrical lactide monomer. PEG-based functional diblock and triblock polylactides were synthesized via a controlled ring-opening p

Process for the preparation of 1-[L-(-)-γ-amino-α-hydroxybutyryl]-kanamycin A (RD-1341A)

1-[L-(-)-γ-amino-α-hydroxybutyryl]-kanamycin A is a compound useful as an antibacterial agent. A new process for its preparation has been developed which comprises using aldehyde blocking agents on the amine functions prior to acylation with L-(-)-γ-amino-α-hydroxybutyric acid.